Major Program
Supportive Care and Symptom Management
NCI Community Oncology Research Program
Research Group
Community Oncology and Prevention Trials
Sponsor
ECOG-ACRIN Cancer Research Group
Status
Recruiting
NCT ID
NCT04597359
This phase II trial studies how well green tea catechins work in preventing progression of prostate cancer from a low risk stage to higher risk stages in men who are on active surveillance. Green tea catechins may stabilize prostate cancer and lower the chance of prostate growing.
Intervention
Placebo Administration, Quality-of-Life Assessment, Questionnaire Administration, Sinecatechins
Condition
Prostate Carcinoma
Investigators
Nagi B Kumar, Jay W. Carlson, Tareq Al Baghdadi, Prem Sobti, Bryan A. Faller, Thomas E. Lad, James A. Wallace, Rex B. Mowat, David M. King, Douglas J. Weckstein, Brandon Mullins, Stephen J. Savage, Steven A. Madden, Mike Cusnir, Robert L. Grubb, Bradley C. Ekstrand, Paul D. Maroni, Izak Faiena, Marc Bjurlin, Kelly L. Stratton, Ryan P. Kopp, Michael A. Liss, Inger L. Rosner, Shahzad Siddique, Matthew H. Hayn, Charles H. Shelton, Site Public Contact, Nitin Yerram, Thomas M. Schroeder, Terrence P. Cescon, Nicholas DiBella, Edward J. Kim, Joseph J. Merchant, Jessica D. McDermott, Luis J. Santos Reyes, Brian L. Burnette, Seema Harichand-Herdt, Costas D. Lallas, Isuru S. Jayaratna, Aditya Bagrodia, Ross E. Krasnow
CT Research Area
Prevention